Dakota Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-6,048
Closed -$473K – 699
2025
Q2
$473K Buy
6,048
+146
+2% +$10.9K 0.01% 527
2025
Q1
$428K Buy
5,902
+10
+0.2% +$716 0.01% 546
2024
Q4
$436K Buy
5,892
+15
+0.3% +$1.05K 0.01% 535
2024
Q3
$388K Sell
5,877
-8,566
-59% -$622K 0.01% 546
2024
Q2
$1.33M Sell
14,443
-383
-3% -$33.9K 0.03% 317
2024
Q1
$1.42M Buy
14,826
+3,329
+29% +$280K 0.04% 306
2023
Q4
$877K Sell
11,497
-1,827
-14% -$127K 0.03% 328
2023
Q3
$923K Buy
13,324
+815
+7% +$65.5K 0.04% 299
2023
Q2
$1.18M Buy
12,509
+5,691
+83% +$495K 0.06% 233
2023
Q1
$564K Buy
6,818
+6
+0.1% +$472 0.04% 344
2022
Q4
$508K Sell
6,812
-554
-8% -$42.7K 0.04% 350
2022
Q3
$609K Sell
7,366
-8,605
-54% -$828K 0.05% 304
2022
Q2
$1.52M Sell
15,971
-13,217
-45% -$1.37M 0.14% 151
2022
Q1
$3.44M Buy
29,188
+737
+3% +$82.7K 0.28% 107
2021
Q4
$3.69M Buy
28,451
+2,429
+9% +$283K 0.39% 69
2021
Q3
$2.95M Buy
26,022
+2,249
+9% +$257K 0.34% 85
2021
Q2
$2.46M Sell
23,773
-1,426
-6% -$134K 0.29% 96
2021
Q1
$2.11M Sell
25,199
-6,463
-20% -$546K 0.28% 98
2020
Q4
$2.89M Buy
31,662
+450
+1% +$37.3K 0.38% 72
2020
Q3
$2.49M Buy
31,212
+22,560
+261% +$1.76M 0.39% 74
2020
Q2
$598K Sell
8,652
-159
-2% -$11.3K 0.1% 153
2020
Q1
$554K Buy
+8,811
New +$635K 0.12% 145

Other funds holding EW

Dakota Wealth Management's EW Position: Q3 2025 in Review

Dakota Wealth Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 6,048 shares — an estimated $473K sold.

Dakota Wealth Management first reported a position in EW in Q1 2020 and held it in 22 quarters. The position peaked at $3.69M in Q4 2021. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Dakota Wealth Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Dakota Wealth Management sold 6,048 Edwards Lifesciences shares in Q3 2025, an estimated $473K.
  • Dakota Wealth Management first reported a position in Edwards Lifesciences in Q1 2020 and held it in 22 quarters.
  • Dakota Wealth Management's Edwards Lifesciences position peaked at $3.69M in Q4 2021.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Dakota Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.